These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Decreased cerebral glucose metabolism in patients with brain tumors: an effect of corticosteroids. Fulham MJ, Brunetti A, Aloj L, Raman R, Dwyer AJ, Di Chiro G. J Neurosurg; 1995 Oct; 83(4):657-64. PubMed ID: 7674016 [Abstract] [Full Text] [Related]
26. Glucose transport across the blood-brain barrier in normal human subjects and patients with cerebral tumours studied using [11C]3-O-methyl-D-glucose and positron emission tomography. Brooks DJ, Beaney RP, Lammertsma AA, Herold S, Turton DR, Luthra SK, Frackowiak RS, Thomas DG, Marshall J, Jones T. J Cereb Blood Flow Metab; 1986 Apr; 6(2):230-9. PubMed ID: 3007547 [Abstract] [Full Text] [Related]
29. Analysis of kinetic rate constants in [18F]fluorodeoxyglucose model using a least square fitting package SALS (statistical analysis with least squares). Uehara S, Kuwabara Y, Ichiya Y, Otsuka M, Ayabe Y, Miyake Y, Masuda K, Yoshimura A. Radioisotopes; 1987 Dec; 36(12):653-6. PubMed ID: 3502293 [Abstract] [Full Text] [Related]
30. Comparison of regional blood-brain transport kinetics between glucose and fluorodeoxyglucose. Lear JL, Ackerman RF. J Nucl Med; 1992 Oct; 33(10):1819-24. PubMed ID: 1403150 [Abstract] [Full Text] [Related]
32. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease]. Arahata Y, Kato T, Tadokoro M, Sobue G. Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454 [Abstract] [Full Text] [Related]
33. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. Ratib O, Phelps ME, Huang SC, Henze E, Selin CE, Schelbert HR. J Nucl Med; 1982 Jul; 23(7):577-86. PubMed ID: 6979614 [Abstract] [Full Text] [Related]
34. Transport of D-glucose and 2-fluorodeoxyglucose across the blood-brain barrier in humans. Hasselbalch SG, Knudsen GM, Holm S, Hageman LP, Capaldo B, Paulson OB. J Cereb Blood Flow Metab; 1996 Jul; 16(4):659-66. PubMed ID: 8964806 [Abstract] [Full Text] [Related]
35. Oral 18F-fluoro-2-deoxyglucose for primate PET studies without behavioral restraint: demonstration of principle. Martinez ZA, Colgan M, Baxter LR, Quintana J, Siegel S, Chatziioannou A, Cherry SR, Mazziotta JC, Phelps ME. Am J Primatol; 1997 Jul; 42(3):215-24. PubMed ID: 9209586 [Abstract] [Full Text] [Related]
36. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy]. Mishina M, Senda M, Ohyama M, Ishii K, Kitamura S, Terashi A. Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328 [Abstract] [Full Text] [Related]
37. [Tomographic measurement of human cerebral glucose metabolism]. Iwasaki Y, Konishi J, Makada Y, Yonekura Y. Nihon Rinsho; 1991 Jul; 49(7):1528-31. PubMed ID: 1886247 [No Abstract] [Full Text] [Related]
38. Positron emission tomography in asphyxiated infants. Preliminary studies of regional cerebral glucose metabolism using 18F-FDG. Suhonen-Polvi H, Ruotsalainen U, Ahonen A, Haaparanta M, Aho K, Riikonen R, Kero P, Korvenranta H, Simell O, Wegelius U. Acta Radiol Suppl; 1991 Jul; 376():173. PubMed ID: 1666770 [No Abstract] [Full Text] [Related]
39. Diagnostic value of kinetic analysis using dynamic 18F-FDG-PET in patients with malignant primary brain tumor. Kimura N, Yamamoto Y, Kameyama R, Hatakeyama T, Kawai N, Nishiyama Y. Nucl Med Commun; 2009 Aug; 30(8):602-9. PubMed ID: 19521265 [Abstract] [Full Text] [Related]
40. Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling. Sugawara Y, Zasadny KR, Grossman HB, Francis IR, Clarke MF, Wahl RL. Radiology; 1999 Apr; 211(1):249-56. PubMed ID: 10189480 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]